Choose Your language:
- Testimonials
-
I have recept my package of viagra and cialis thanks you
- joe
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- FDA to review CV risk with azithromycin - TheHeart.Org
- FDA to review CV risk with azithromycinTheHeart
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - MarketWatch (press release)
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - PR Newswire (press release)
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in
- Pernix Therapeutics Reports First Quarter 2012 Financial Results - EON: Enhanced Online News (press release)
- Pernix Therapeutics Reports First Quarter 2012 Financial ResultsEON: Enhanced Online News (press release)Omeclamox-Pak® is a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H
- Popular Antibiotic May Raise Risk of Sudden Death - New York Times
- New York TimesPopular Antibiotic May Raise Risk of Sudden DeathNew York TimesTwo related antibiotics, erythromycin and clarithromycin, were already known to raise the risk of sudden death
